Improving Hypertension Control in Rheumatoid Arthritis
This study is looking at ways to better manage high blood pressure (hypertension) in people who also have rheumatoid arthritis (RA), an autoimmune disease. We know that people with RA often have poorly controlled high blood pressure, which can increase their risk of heart problems. This study will test a "Blood pressure intervention arm" which focuses on helping you take a more active role in your blood pressure care, improving communication with your doctors, and creating a team approach to manage your blood pressure. We want to see if this intervention is practical to implement, measured by how many people join and stay in the study, and how well they monitor their blood pressure. You can join if you are 18 or older, have uncontrolled high blood pressure and rheumatoid arthritis, and receive both primary and rheumatology care at Duke Health System. The study plans to enroll 25 participants, but its current status is unclear.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 25 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure outcomes for 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Hypertension Control in Rheumatoid Arthritis
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Intervention feasibility as measured by participant accrual rates6 months
Rate at which participants are able to be successfully recruited
- Intervention feasibility as measured by participant retention6 months
Percentage of participants who successfully complete the study
- Intervention feasibility as measured by adherence to blood pressure monitoring6 months
Percentage of expected blood pressures reported by participants
- Intervention feasibility as measured by adherence to survey reporting6 months
Percentage of expected surveys completed by participants
- Intervention feasibility as measured by sample characteristics6 months
Description of sociodemographic characteristics of population, rheumatoid arthritis characteristics (eg, duration, medications, severity), and hypertension characteristics (eg, duration, medications, severity)
- Intervention feasibility as measured by use of resources6 months
Cost of participant recruitment, education, blood pressure monitors, participant compensation, research coordinator time and cost needed to collect data, and statistical analysis
- Intervention feasibility as measured by sustainability of data collection procedures6 months
Financial and time commitments required to successfully collect participant surveys, blood pressure monitoring results, send information to providers, and monitor provider responses
- Intervention acceptability as measured by qualitative interviews6 months
Qualitative interviews will be performed at the end of the pilot intervention with all study participants to assess the acceptability of the intervention. Rheumatology and primary care providers caring for study participants will also be invited to comment on the acceptability of the intervention.
- Perceived appropriateness of the intervention to address the health care disparity in HTN (hypertension) control for Black RA patients as measured by qualitative interviews6 months
Qualitative interviews will be performed at the end of the pilot intervention with all study participants to assess the perceived appropriateness of the intervention to address the health care disparity in HTN control for Black RA patients. Rheumatology and primary care providers caring for study participants will also be invited to comment on the appropriateness of the intervention.
- Barriers to and enablers of participating in the intervention as measured by qualitative interviews6 months
Qualitative interviews will be performed at the end of the pilot intervention with all study participants to assess barriers to and enablers of participating in the intervention.